Components:
Method of action:
Treatment option:
Medically reviewed by Militian Inessa Mesropovna, PharmD. Last updated on 15.03.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Cytomegalovirus infection( CMV): prevention in patients with immunodeficiency, immunosuppression (especially after transplantation) and treatment in patients with weakened immunity (premature infants, newborns or infants, AIDS, taking immunosuppressants, etc.).
V/v (before administration, the solution is heated to room temperature or body temperature), at a rate of no more than 20 drops / min (1 ml / min). Prevention of cytomegalovirus infection: in a single dose of 1 ml / kg, for organ transplantation-on the day of transplantation, for bone marrow transplantation - on the day before transplantation. In CMV-seropositive patients, prevention begins 10 days before transplantation. The course is 6 single doses with an interval of 2-3 weeks.
Therapy of cytomegalovirus infection: in a single dose of 2 ml / kg every 2 days until the disappearance of clinical symptoms.
Hypersensitivity.
Headache, chills, fever, nausea, vomiting, joint aches, back pain, allergic reactions. Rarely-a decrease in blood pressure, in isolated cases-anaphylactic shock, symptoms of aseptic meningitis (severe headache, nausea, vomiting, fever, stiffness of the occipital muscles, photosensitivity, impaired consciousness), exacerbation of renal failure in patients with impaired renal function.
Symptoms: hypervolemia, increased blood viscosity (especially in patients with impaired renal function or the elderly).
- Immunoglobulins
Weakens the effectiveness of live viral vaccines (against measles, rubella, mumps, chickenpox).
In a dark place, at a temperature of 2-8 °C (do not freeze).
Keep out of reach of children.
The shelf life of the drug Cytotec3 года.Do not use after the expiration date indicated on the package.
| Solution for injection 10 % | 1 ml |
| human plasma proteins | 100 mg |
| (of these, IG ≥ 95%, including antibodies against CMV 50 units of the comparative preparation of the Paul Ehrlich Institute) |
in ampoules of 10 and 20 ml or in vials of 50 ml, in a cardboard pack 1 ampoule or 1 bottle.
With caution.
It can only be mixed with 0.9% sodium chloride solution.
Perhaps the appearance of false-positive data in a serological study.
J06BB09 Human Immunoglobulin Anti-cytomegalovirus
- B20-B24 Disease caused by human immunodeficiency virus [HIV]
- B25 Cytomegalovirus disease
- D84. 9 Immunodeficiency, unspecified
- Z29. 1 Preventive immunotherapy
Colorless or light yellow transparent or slightly opalescent solution.
